-
-
-
-
-
-
-
Exicure nears phase 2 data readout for blood cancer drug burixafor
-
-
-
-
-
-
-
Exicure Inc. (XCUR) Announces 1-for-5 Reverse Stock Split
-
-
421,631 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

